| The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer AM Krebs, J Mitschke, M Lasierra Losada, O Schmalhofer, M Boerries, ... Nature cell biology 19 (5), 518-529, 2017 | 878 | 2017 |
| Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after PANCreatoduodenectomy (RECOPANC, DRKS 00000767): perioperative and long-term results of a multicenter … T Keck, UF Wellner, M Bahra, F Klein, O Sick, M Niedergethmann, ... Annals of surgery 263 (3), 440-449, 2016 | 372 | 2016 |
| Cancer cell invasion and EMT marker expression: a three‐dimensional study of the human cancer–host interface P Bronsert, K Enderle‐Ammour, M Bader, S Timme, M Kuehs, A Csanadi, ... The Journal of pathology 234 (3), 410-422, 2014 | 336 | 2014 |
| ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in … J Hoeppner, F Lordick, T Brunner, T Glatz, P Bronsert, N Röthling, ... BMC cancer 16, 1-10, 2016 | 310 | 2016 |
| Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions M Schwabenland, H Salié, J Tanevski, S Killmer, MS Lago, AE Schlaak, ... Immunity 54 (7), 1594-1610. e11, 2021 | 235 | 2021 |
| ZEB 1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat S Meidhof, S Brabletz, W Lehmann, BT Preca, K Mock, M Ruh, J Schüler, ... EMBO molecular medicine 7 (6), 831-847, 2015 | 225 | 2015 |
| Spatially confined sub-tumor microenvironments in pancreatic cancer BT Grünwald, A Devisme, G Andrieux, F Vyas, K Aliar, CW McCloskey, ... Cell 184 (22), 5577-5592. e18, 2021 | 212 | 2021 |
| Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO … E Fokas, A Schlenska-Lange, B Polat, G Klautke, GG Grabenbauer, ... JAMA oncology 8 (1), e215445-e215445, 2022 | 167 | 2022 |
| ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival SM Gilbert, CJ Oliphant, S Hassan, AL Peille, P Bronsert, S Falzoni, ... Oncogene 38 (2), 194-208, 2019 | 158 | 2019 |
| Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer E Pérez-Gómez, C Andradas, S Blasco-Benito, MM Caffarel, ... Journal of the National Cancer Institute 107 (6), djv077, 2015 | 119 | 2015 |
| Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate-and high-risk prostate cancer-a … C Zamboglou, M Carles, T Fechter, S Kiefer, K Reichel, TF Fassbender, ... Theranostics 9 (9), 2595, 2019 | 110 | 2019 |
| L1CAM expression in endometrial carcinomas: an ENITEC collaboration study LJM Van Der Putten, N Visser, K Van de Vijver, M Santacana, P Bronsert, ... British journal of cancer 115 (6), 716-724, 2016 | 106 | 2016 |
| Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer P Bronsert, I Kohler, S Timme, S Kiefer, M Werner, O Schilling, Y Vashist, ... Surgery 156 (1), 97-108, 2014 | 103 | 2014 |
| SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis T Boettler, B Csernalabics, H Salié, H Luxenburger, L Wischer, ES Alizei, ... Journal of Hepatology 77 (3), 653-659, 2022 | 102 | 2022 |
| A four-chemokine signature is associated with a T-cell–inflamed phenotype in primary and metastatic pancreatic cancer JM Romero, B Grünwald, GH Jang, PP Bavi, A Jhaveri, M Masoomian, ... Clinical Cancer Research 26 (8), 1997-2010, 2020 | 102 | 2020 |
| Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations B Kulemann, S Rösch, S Seifert, S Timme, P Bronsert, G Seifert, V Martini, ... Scientific reports 7 (1), 4510, 2017 | 98 | 2017 |
| Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET C Stoykow, T Erbes, HR Maecke, S Bulla, M Bartholomä, S Mayer, ... Theranostics 6 (10), 1641, 2016 | 94 | 2016 |
| [68Ga-] PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard … AS Bettermann, C Zamboglou, S Kiefer, CA Jilg, S Spohn, ... Radiotherapy and Oncology 141, 214-219, 2019 | 91 | 2019 |
| Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary … P Bronsert, I Kohler, M Werner, F Makowiec, S Kuesters, J Hoeppner, ... BMC cancer 13, 1-13, 2013 | 91 | 2013 |
| KDM4 inhibition targets breast cancer stem–like cells E Metzger, SS Stepputtis, J Strietz, BT Preca, S Urban, D Willmann, ... Cancer research 77 (21), 5900-5912, 2017 | 87 | 2017 |
Ulrich WellnerUKSH Campus LübeckVerified email at uksh.de
Ulrich WellnerUKSH Campus LübeckVerified email at uksh.de